摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-氨基-1-丙基-1H-咪唑-4-甲酰胺 | 61507-88-8

中文名称
5-氨基-1-丙基-1H-咪唑-4-甲酰胺
中文别名
——
英文名称
5-amino-1-propyl-1H-imidazole-4-carboxamide
英文别名
5-amino-1-propylimidazole-4-carboxamide;5-amino-1-n-propylimidazole-4-carboxamide
5-氨基-1-丙基-1H-咪唑-4-甲酰胺化学式
CAS
61507-88-8
化学式
C7H12N4O
mdl
MFCD09864516
分子量
168.198
InChiKey
LVONFJCKVYNYTJ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    0.3
  • 重原子数:
    12
  • 可旋转键数:
    3
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.428
  • 拓扑面积:
    86.9
  • 氢给体数:
    2
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2934999090

SDS

SDS:d4ea3b1524080e103094141b03939b18
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-氨基-1-丙基-1H-咪唑-4-甲酰胺sodium hydroxide 、 copper diacetate 、 potassium carbonate 作用下, 以 甲醇丙酮 为溶剂, 反应 11.0h, 生成 9-propylguanine
    参考文献:
    名称:
    A simple and efficient synthesis of 9-substituted guanines. Cyclodesulfurization of 1-substituted 5-[(thiocarbamoyl)amino]imidazole-4-carboxamides under aqueous basic conditions
    摘要:
    5-Aminoimidazole-4-carboxamide (AICA) (1a) is 1-alkylated by an improved method. The resulting 5-amino-1-alkylimidazole-4-carboxamides (1b-i) are converted to the corresponding 1-alkyl-5-[(thiocarbamoyl)-amino]imidazole-4-carboxamides (3). These compounds are ring closed under alkaline conditions to 9-substituted guanines (5) in very high yields by treatment with heavy-metal salts in aqueous sodium hydroxide, or, in somewhat lower yields, by S-oxidation with hydrogen peroxide or sodium perborate in aqueous sodium hydroxide.
    DOI:
    10.1021/jo00006a033
  • 作为产物:
    参考文献:
    名称:
    A simple and efficient synthesis of 9-substituted guanines. Cyclodesulfurization of 1-substituted 5-[(thiocarbamoyl)amino]imidazole-4-carboxamides under aqueous basic conditions
    摘要:
    5-Aminoimidazole-4-carboxamide (AICA) (1a) is 1-alkylated by an improved method. The resulting 5-amino-1-alkylimidazole-4-carboxamides (1b-i) are converted to the corresponding 1-alkyl-5-[(thiocarbamoyl)-amino]imidazole-4-carboxamides (3). These compounds are ring closed under alkaline conditions to 9-substituted guanines (5) in very high yields by treatment with heavy-metal salts in aqueous sodium hydroxide, or, in somewhat lower yields, by S-oxidation with hydrogen peroxide or sodium perborate in aqueous sodium hydroxide.
    DOI:
    10.1021/jo00006a033
点击查看最新优质反应信息

文献信息

  • Comparison of different heterocyclic scaffolds as substrate analog PDE5 inhibitors
    作者:Helmut Haning、Ulrich Niewöhner、Thomas Schenke、Thomas Lampe、Alexander Hillisch、Erwin Bischoff
    DOI:10.1016/j.bmcl.2005.05.090
    日期:2005.9
    Several different heterocyclic systems were compared as PDE5 inhibitor scaffolds. In addition to the known 3H-imidazo[5,1-f][1,2,4]triazin-4-ones and pyrazolopyrimidinones, isomeric imidazo[1,5-a][1,3,5]triazin-4(3H)-ones were also shown to be potent and selective PDE inhibitor scaffolds with in vivo activity. SAR trends were elucidated for sulfonamide derivatives with generality across different scaffolds
    比较了几种不同的杂环系统作为PDE5抑制剂支架。除了已知的3H-咪唑并[5,1-f] [1,2,4]三嗪-4-酮和吡唑并吡喃二酮外,咪唑并[1,5-a] [1,3,5]三嗪-4( 3H)-一也被证明是具有体内活性的有效的和选择性的PDE抑制剂支架。阐明了在不同支架上具有普遍性的磺酰胺衍生物的SAR趋势。
  • Purinone antianginal agents
    申请人:Pfizer Inc
    公开号:US05734053A1
    公开(公告)日:1998-03-31
    ##STR1## Compounds of formula (I), and pharmaceutically acceptable salts thereof, wherein R.sup.1 is C.sub.1 -C.sub.4 alkyl; R.sup.2 is C.sub.2 -C.sub.4 alkyl; R.sup.3 is H or SO.sub.2 NR.sup.4 R.sup.5 ; R.sup.4 and R.sup.5 together with the nitrogen atom to which they are attached form a pyrrolidino, piperidino, morpholino or 4-N-(R.sup.6)-1-piperazinyl group; and R.sup.6 is H or C.sub.1 -C.sub.3 alkyl; are selective cGMP PDE inhibitors useful in the treatment of, inter alia, cardiovascular disorders such as angina, hypertension, heart failure and atherosclerosis.
    公式(I)的化合物及其药用盐,其中R.sup.1为C.sub.1-C.sub.4烷基;R.sup.2为C.sub.2-C.sub.4烷基;R.sup.3为H或SO.sub.2NR.sup.4R.sup.5;R.sup.4和R.sup.5与它们连接的氮原子一起形成吡咯啉基、哌啶基、吗啉基或4-N-(R.sup.6)-1-哌嗪基;R.sup.6为H或C.sub.1-C.sub.3烷基;是选择性cGMP PDE抑制剂,可用于治疗心血管疾病,如心绞痛、高血压、心力衰竭和动脉粥样硬化等。
  • [EN] A PROCESS FOR THE PREPARATION OF 9-SUBSTITUTED GUANINE DERIVATIVES AND INTERMEDIATES FOR USE IN THE PROCESS
    申请人:A/S GEA FARMACEUTISK FABRIK
    公开号:WO1990011283A1
    公开(公告)日:1990-10-04
    (EN) A process for the preparation of 9-substituted guanine derivatives of general formula (I), in which R is C1-C4-alkyl optionally substituted with one or more hydroxy groups, or R is ($g(a)), benzyl, ribosyl, 2'-deoxyribosyl or (CH2)n-OR1 where n is 1 or 2, and R1 is CH2CH2OH or ($g(b)) or salts thereof, in which a 1-substituted 5-(thiocarbamoyl)amino-1H-imidazole-4-carboxamide of general formula (III), where R has the same meaning as in formula (I), is cyclized: a) by treatment with a heavy metal salt of the group of Cu-, Ag-, Pb- and Hg-salts in an aqueous alkaline medium containing at least four equivalents of OH-ions at a temperature from about 0°C to the reflux temperature, or b) by treatment with a peroxy compound in an aqueous alkaline medium at a temperature of about 0-30°C, whereafter (I) is isolated by treatment with acid and, if desired, is converted into a salt. The invention further comprises intermediates for use in the preparation of the above-mentioned compounds.(FR) L'invention concerne un procédé de préparation de dérivés de guanine substitués en position 9, selon la formule générale (I), dans laquelle R représente alcoyle C1-C4 facultativement remplacé par un ou plusieurs groupes hydroxy, où R représente ($g(a)), benzyle, ribosyle, 2'-désoxyribosyle ou (CH2)n-OR1 où n représente 1 ou 2, et R1 représente CH2CH2OH ou ($g(b)), ou leurs sels, dans lequel un 5-(thiocarbamoyle) amino-1H-imidazole-4-carboxamide substitué en position 1, de la formule générale (III), dans laquelle R est défini comme dans la formule (I), est cyclisé: a) par traitement à l'aide d'un sel de métal lourd du groupe composé de sels de Cu, Ag, Pb et Hg dans un milieu alcalin aqueux contenant au moins quatre équivalents d'ions OH-, à température comprise entre environ 0°C et la température de reflux ou b) par traitement à l'aide d'un composé peroxy dans un milieu alcalin aqueux à une température comprise entre environ 0 et 30°C, après quoi (I) est isolé par traitement à l'acide, et si désiré, est transformé en un sel. L'invention comprend en outre des intermédiaires utilisés dans la préparation des composés précités.
    一种制备9-取代鸟嘌呤衍生物的方法,其一般式为(I),其中R是C1-C4烷基,可选择地取代一个或多个羟基,或者R是($g(a)),苄基,核糖基,2'-去氧核糖基或(CH2)n-OR1,其中n为1或2,R1为CH2CH2OH或($g(b))或其盐,其中通过将一种一般式(III)的1-取代5-(硫氨酰)氨基-1H-咪唑-4-羧酰胺,其中R与公式(I)中的含义相同,进行环化:a)通过在含有至少四当量OH-离子的水性碱性介质中,用Cu-、Ag-、Pb-和Hg-盐中的重金属盐处理,在0°C至沸点温度范围内进行,或b)通过在水性碱性介质中使用过氧化物化合物,在约0-30°C的温度下进行处理,然后通过酸处理分离出(I),如有需要,转化为盐。该发明还包括用于制备上述化合物的中间体。
  • Studies on the π–π stacking features of imidazole units present in a series of 5-amino-1-alkylimidazole-4-carboxamides
    作者:Sibdas Ray、Aniruddha Das
    DOI:10.1016/j.molstruc.2015.02.032
    日期:2015.6
    Reaction of 2-ethoxymethyleneamino-2-cyanoacetamide with primary alkyl amines in acetonitrile solvent affords 1-substituted-5-aminoimidazole-4-carboxamides. Single crystal X-ray diffraction studies of these imidazole compounds show that there are both anti-parallel and syn-parallel pi-pi stackings between two imidazole units in parallel-displaced (PD) conformations and the distance between two pi-pi stacked imidazole units depends mainly on the anti/ syn-parallel nature and to some extent on the alkyl group attached to N-1 of imidazole; molecules with anti-parallel PD-stacking arrangements of the imidazole units have got vertical pi-pi stacking distance short enough to impart stabilization whereas the imidazole unit having syn-parallel stacking arrangement have got much larger pi-pi stacking distances. DFT studies on a pair of anti-parallel imidazole units of such an AICA lead to curves for 'pi-pi stacking stabilization energy vs. pi-pi stacking distance' which have got similarity with the 'Morse potential energy diagram for a diatomic molecule' and this affords to find out a minimum pi-pi stacking distance corresponding to the maximum stacking stabilization energy between the pair of imidazole units. On the other hand, a DFT calculation based curve for 'pi-pi stacking stabilization energy vs. pi-pi stacking distance' of a pair of syn-parallel imidazole units is shown to have an exponential nature. (C) 2015 Elsevier B.V. All rights reserved.
  • ALNEDE, VZHUSTORGE;SLAUSEN, FINN PRIESS;JUHL-CHRISTENSEN, JZHUSTORGEN;MSS+, J. ORG. CHEM., 56,(1991) N, C. 2139-2143
    作者:ALNEDE, VZHUSTORGE、SLAUSEN, FINN PRIESS、JUHL-CHRISTENSEN, JZHUSTORGEN、MSS+
    DOI:——
    日期:——
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物